Analyst firms · Raymond James · GDRX
Raymond James GDRX price target and rating history
GoodRx Holdings Inc. (GDRX) · Technology
Raymond James rates GoodRx Holdings Inc. (GDRX) Outperform with a $10 price target, as of its latest action on Aug 11, 2025. It has published 6 rating actions on GDRX since August 2021, including 3 upgrades and 2 downgrades.
- Current rating
- Outperform
- Price target
- $10
- Median target, all firms
- Too few
- Actions on GDRX
- 6
Raymond James price target on GDRX
Every Raymond James rating on GDRX
- Aug 11, 2025
- Aug 9, 2024
- May 16, 2024
- May 10, 2022
- Mar 2, 2022
- Aug 13, 2021
How other firms rate GDRX
Each firm's latest rating and stated target in the last 12 months.
Questions about Raymond James and GDRX
- What is Raymond James's price target for GDRX?
- Raymond James's latest stated price target for GoodRx Holdings Inc. (GDRX) is $10, from its action on Aug 9, 2024.
- What is Raymond James's rating on GDRX?
- Raymond James rates GDRX Outperform, a bullish rating, as of Aug 11, 2025.
- When did Raymond James last change its view on GDRX?
- On Aug 11, 2025, Raymond James downgrades to Outperform from Strong Buy.
More GDRX rating histories
- Barclays5
- RBC Capital Markets3
- J.P. Morgan3
- Leerink Partners4
- BofA Securities3
- TD Cowen3
- Goldman Sachs3
- Credit Suisse3
- Morgan Stanley3
All Raymond James ratingsGDRX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.